CAR T-Cell Therapy Approved for Some Children and Young Adults with Leukemia

FDA has approved tisagenlecleucel (Kymriah™), a type of immunotherapy called CAR T-cell therapy, for some children and young adults with advanced acute lymphoblastic leukemia (ALL).

Cancer Currents: An NCI Cancer Research Blog